| Welscare Of South Carolina, Llc | |
|
111 Lovett Dr, Greenville, SC 29607-6510 | |
| (801) 869-4100 | |
| (208) 869-4119 |
| Full Name | Welscare Of South Carolina, Llc |
|---|---|
| Type | Facility |
| Speciality | Nurse Practitioner |
| Location | 111 Lovett Dr, Greenville, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679250146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Secondary |
| 363L00000X | Nurse Practitioner | (* (Not Available)) | Primary |
| Provider Name | Eric Joseph Thomas |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1306107313 PECOS PAC ID: 0840505871 Enrollment ID: I20230824003676 |
News Archive
The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
Most will agree that two heads are better than one in solving problems. The same logic may be true for language and retaining cognitive processes as we age. Being fluent in two languages seems to prevent some of the cognitive decline seen in same-age monolingual speaking persons, according to the findings of a study appearing in this month's journal of Psychology and Aging.
In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 255-261(7); DOI: https://doi.org/10.15212/CVIA.2017.0061 Syed Raza Shah and Ki Park from UCF/HCA GME Consortium Internal Medicine, Gainesville, FL, USA and Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA consider the contemporary role of femoral artery access.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
› Verified 3 days ago
| Provider Name | Rachael A Bennett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518575695 PECOS PAC ID: 0941610315 Enrollment ID: I20231206003469 |
News Archive
The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
Most will agree that two heads are better than one in solving problems. The same logic may be true for language and retaining cognitive processes as we age. Being fluent in two languages seems to prevent some of the cognitive decline seen in same-age monolingual speaking persons, according to the findings of a study appearing in this month's journal of Psychology and Aging.
In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 255-261(7); DOI: https://doi.org/10.15212/CVIA.2017.0061 Syed Raza Shah and Ki Park from UCF/HCA GME Consortium Internal Medicine, Gainesville, FL, USA and Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA consider the contemporary role of femoral artery access.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
› Verified 3 days ago
| Provider Name | Dianna Fort |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598536310 PECOS PAC ID: 7214372341 Enrollment ID: I20240228004334 |
News Archive
The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
Most will agree that two heads are better than one in solving problems. The same logic may be true for language and retaining cognitive processes as we age. Being fluent in two languages seems to prevent some of the cognitive decline seen in same-age monolingual speaking persons, according to the findings of a study appearing in this month's journal of Psychology and Aging.
In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 255-261(7); DOI: https://doi.org/10.15212/CVIA.2017.0061 Syed Raza Shah and Ki Park from UCF/HCA GME Consortium Internal Medicine, Gainesville, FL, USA and Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA consider the contemporary role of femoral artery access.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Welscare Of South Carolina, Llc 1250 E 3900 S Ste 440, Salt Lake City, UT 84124-1349 Ph: (801) 869-4100 | Welscare Of South Carolina, Llc 111 Lovett Dr, Greenville, SC 29607-6510 Ph: (801) 869-4100 |
News Archive
The reviews appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
Most will agree that two heads are better than one in solving problems. The same logic may be true for language and retaining cognitive processes as we age. Being fluent in two languages seems to prevent some of the cognitive decline seen in same-age monolingual speaking persons, according to the findings of a study appearing in this month's journal of Psychology and Aging.
In the current issue of Cardiovascular Innovations and Applications (Volume3,Number 2, 2018, pp. 255-261(7); DOI: https://doi.org/10.15212/CVIA.2017.0061 Syed Raza Shah and Ki Park from UCF/HCA GME Consortium Internal Medicine, Gainesville, FL, USA and Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA consider the contemporary role of femoral artery access.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
› Verified 3 days ago